Sevoflurane/Desflurane

PreclinicalSmall molecule

Sevoflurane/Desflurane is one of 4 small molecule programs targeting Laryngeal Mask Airway. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Laryngeal Mask AirwayCompleted

Laryngeal Mask AirwayPreclinical

Completed

Competition

Competitive Landscape

4 competitors in Laryngeal Mask Airway

#DrugCompanyPhaseTrials

Nimbex

AbbVie

Preclinical

1 2

Alfenta

Jazz Pharmaceuticals

Preclinical

1 3

Remimazolam TIVA

YYonsei University

Preclinical

1 4

Sevoflurane/Desflurane

SSeoul National University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Laryngeal Mask Airway1 trial

Desflurane in Children With Laryngeal Mask Airway

Completed·SSeoul National University Hospital·N/A·NCT02470442·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Sevoflurane/Desflurane. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sevoflurane/Desflurane compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sevoflurane/Desflurane. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSeoul National University Hospital

Sevoflurane/Desflurane

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Laryngeal Mask Airway1 trial

References

Drug Info

Quick Facts

Related News